The purpose of this study is to develop plasmid DNA-coated positively charged PLGA nanoparticles and to evaluate the ability of these nanoparticles to induce immune responses, including mucosal immunity, after they are administered onto a mouse skin area pretreated with microneedles. Methods Cationic PLGA nanoparticles were prepared by the nanoprecipitation-solvent evaporation method using PLGA and DOTAP. Plasmid DNA (pCMV-β or pCI-neo-sOVA) was coated on the surface of the cationic nanoparticles by gently mixing equal volumes of cationic nanoparticles with plasmid DNA. The mixing ratio was adjusted so that the final charge on the surface of the resultant nanoparticles is positive. Mice were immunized with the net positively charged DNA-coated nanoparticles transcutaneously on a skin area pretreated with microneedles. Antibody responses in serum, fecal, and bronchoalveolar lavage (BAL) fluid samples were determined using ELISA. Cellular immune responses were measured by ELISPOT using splenocytes isolated from the immunized mice.
